CytomX Therapeutics
A biotechnology company that develops Probodies, proteolytically-activated antibodies to treat cancer.
Key facts
| AngelList URL | https://angel.co/cytomx-therapeutics |
|---|---|
| CAGE Code | 6Y2S4 |
| Legal Name | CytomX Therapeutics, Inc. |
| Company Operating Status | Active |
| Crunchbase URL | https://www.crunchbase.com/organization/cytomx-therapeutics?utm_source=linkedin&utm_medium=referral&utm_campaign=linkedin_companies&utm_content=profile_cta |
| Full Address | 151 Oyster Point Blvd, Suite 400 South San Francisco, CA 94080-1913, USA |
| LinkedIn URL | https://www.linkedin.com/company/cytomx-therapeutics |
| Pitchbook URL | https://pitchbook.com/profiles/company/51019-21 |
| Stock Symbol | CTMX |
| Ticker Symbol | CTMX |
| Twitter URL | https://twitter.com/cytomxinc |
| Official Website | https://cytomx.com |
| Wellfound ID | cytomx-therapeutics |
Contact details
Email and phone for CytomX Therapeutics are available to signed-in members of PharmaLyt.
Sign in to view